Buy now! Experts say 8 stocks to see 22-130% Q1 profit growth
Sat, Jul 06, 2013 at 16:12
Q1FY14 Profit (estimates): Rs 182 crore
YoY jump (estimates): 130.4%
Target: Rs 271
Rationale: Aurobindo Pharma is expected to post a net sales growth of 38.7% YoY. The margins are likely to expand to 16.2% vs 10.3% in 1QFY2014, which will lead the net profit of Rs 182cr vs Rs 79cr in 1QFY2014.